This study examined whether administering neoadjuvant therapy (nat) followed by surgical resection is safe and effective in pancreatic ductal adenocarcinoma (PDAC) patients aged 75 and older. In a comprehensive three-part analysis, the research found that this aggressive treatment approach appears to be both safe and effective for older patients. Notably, it led to improved outcomes in terms of overall survival (OS) and time to recurrence (TTR) compared to upfront surgical resection, supporting the idea that older adults with PDAC should be offered this multimodal treatment approach.
Journal Article by Qiao G, Fong ZV (…) Qadan M et 16 al. in Ann Surg
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.